srch

Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on two core ...

We are the leader in discovering and developing RNA-targeted therapeutics. Our efficient, broadly applicable drug discovery platform, called antisense technology, can treat illnesses where no other therapeutic approaches have proven effective or ever existed. Learn more about our Ionis Innovations Once in a lifetime breakthroughs again and again

Ionis Pharmaceuticals, Inc. | 26371 followers on LinkedIn. YES happens here @Ionispharma | For more than 30 years, Ionis has been the leader in RNA-targeted ...

Our Medicines | Ionis Pharmaceuticals, Inc. Our Medicines Treating the untreatable Our passion for patients in need fuels our dedication to fill the therapeutic void with hope for the future. With RNA as the basis of our discovery platform, we are able to bring therapeutic options to patients who otherwise would have none.

Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics.

We are the leader in discovering and developing RNA-targeted therapeutics. Our efficient, broadly applicable drug discovery platform, called antisense ...

Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen) and has 4 drugs in pivotal studies: tominersen for Huntington’s disease, tofersen for SOD1-ALS, AKCEA-A…

Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad California 92010. United States. Website: http://www.ionispharma.com/ · Show jobs for this employer ...

Ionis is focused on delivering RNA-targeted therapeutics with transformational potential. Our antisense oligonucleotide drug discovery platform has transformed the lives of patients with devastating diseases, including SMA, hATTR, and FCS.

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced it has entered into a strategic collaboration agreement with ...

Ionis is THE leading innovator in RNA-targeted therapeutics and was purposely designed to: Create a better, more efficient drug discovery platform Establish a new innovation-centered business model, and Maximize the value of every medicine …

Ionis Pharmaceuticals, Inc. Analyst Report: Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad...